Abstract:Background: Cyclic vomiting syndrome (CVS) is an enigmatic and debilitating disorder of gut-brain interaction that is characterized by recurrent episodes of severe vomiting and nausea. It significantly impairs patients' quality of life and can lead to frequent medical visits and substantial health care costs. The diagnosis for CVS is often protracted and complex, primarily due to its exclusionary diagnosis nature and the lack of specific biomarkers. This typically leads to a considerable delay in accurate diagnosis, contributing to increased patient morbidity. Additionally, the absence of approved therapies for CVS worsens patient hardship and reflects the urgent need for innovative, patient-centric solutions to improve CVS management. Objective: We aim to develop a digital patient assistant (DPA) for patients with CVS to address their unique needs, and iteratively enhance the technical features and user experience on the initial DPA versions. Methods: The development of the DPA for CVS used a design thinking approach, prioritizing user needs. A literature review and Patient Advisory Board shaped the initial prototype, focusing on diagnostic support and symptom tracking. Iterative development, informed by the design thinking approach and feedback from patients with CVS and caregivers through interviews and smartphone testing, led to significant enhancements in user interaction and artificial intelligence integration. The final DPA's effectiveness was validated using the System Usability Scale and feedback questions, ensuring it met the specific needs of the CVS community. Results: The DPA developed for CVS integrates an introductory bot, daily and weekly check-in bots, and a knowledge hub, all accessible via a patient dashboard. This multicomponent solution effectively addresses key unmet needs in CVS management: efficient symptom and impacts tracking, access to comprehensive disease information, and a digital health platform for disease management. Significant improvements, based on user feedback, include the implementation of artificial intelligence features like intent recognition and data syncing, enhancing the bot interaction and reducing the burden on patients. The inclusion of the knowledge hub provides educational resources, contributing to better disease understanding and management. The DPA achieved a System Usability Scale score of 80 out of 100, indicating high ease of use and relevance. Patient feedback highlighted the DPA's potential in disease management and suggested further applications, such as integration into health care provider recommendations for patients with suspected or confirmed CVS. This positive response underscores the DPA's role in enhancing patient engagement and disease management through a patient-centered digital solution. Conclusions: The development of this DPA for patients with CVS, via an iterative design thinking approach, offers a patient-centric solution for disease management. The DPA development framework may also serve to guide future patient digital support and research scenarios.

S803 Recent Findings on Clinical and Economic Outcomes of Cyclic Vomiting Syndrome: An Analysis of the National Inpatient Database

Advances of diagnosis in children with cyclic vomiting syndrome

Exploring cyclic vomiting syndrome (CVS) worldwide: Current epidemiological insights and recent developments

S782 Nutritional Status and Eating Patterns in Patients With Cyclic Vomiting Syndrome

Worldwide Prevalence and Description of Cyclic Vomiting Syndrome According to the Results of the Rome Foundation Global Epidemiology Study

Cyclic vomiting syndrome: A narrative review and guide to management

Cyclic Vomiting Syndrome in Children and Adults: What Is New in 2018?

Cyclic vomiting syndrome: Future clinical and research priorities for: Special supplement/proceedings of 3rd international symposium

Migraine, Cyclic Vomiting Syndrome, and Other Gastrointestinal Disorders

Treatment principles in adults and development of patient‐reported outcomes in cyclic vomiting syndrome

Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association

Distinguishing Clinical Features of Cannabinoid Hyperemesis Syndrome and Cyclic Vomiting Syndrome: A Retrospective Cohort Study

Children with Cyclic Vomiting Syndrome: Phenotypes, Disease Burden and Mitochondrial DNA Analysis

Perspectives, experiences, and concerns with cyclical vomiting syndrome: Insights from online targeted‐disease forums

Cardiac Vagal Regulation is Impeded in Children with Cyclic Vomiting Syndrome

A call to action [plans] for cyclic vomiting syndrome

Development of a Digital Patient Assistant for the Management of Cyclic Vomiting Syndrome: Patient-Centric Design Study

Cyclic vomiting syndrome: features to be explained by a pathophysiologic model

Follow-up of children with cyclic vomiting syndrome: Combination therapy effects and clinical features

Cyclic vomiting syndrome in pediatric population: characteristics and prophylactic response to cyproheptadine

Cyclic Vomiting Syndrome in Patients Affected by Jansen–de Vries Syndrome: Results From an International Survey